Nukewatch

Working for a nuclear-free future since 1979

  • Issues
    • Weekly Column
    • Counterfeit Reactor Parts
    • Depleted Uranium
    • Direct Action
    • Lake Superior Barrels
    • Environmental Justice
    • Nuclear Power
      • Chernobyl
      • Fukushima
    • Nuclear Weapons
    • On The Bright Side
    • Radiation Exposure
    • Radioactive Waste
    • Renewable Energy
    • Uranium Mining
    • US Bombs Out of Germany
  • Quarterly Newsletter
    • Quarterly Newsletter
    • Newsletter Archives
  • Resources
    • Nuclear Heartland Book
    • Fact Sheets
    • Reports, Studies & Publications
      • The New Nuclear Weapons: $1.74 Trillion for H-bomb Profiteers and Fake Cleanups
      • Nuclear Power: Dead In the Water It Poisoned
      • Thorium Fuel’s Advantages as Mythical as Thor
      • Greenpeace on Fukushima 2016
      • Drinking Water at Risk: Toxic Military Wastes Haunt Lake Superior
    • Nukewatch in the News
    • Links
    • Videos
  • About
    • About Nukewatch
    • Contact Us
  • Get Involved
    • Action Alerts!
    • Calendar
    • Workshops
  • Donate

May 2, 2016 by Nukewatch Leave a Comment

Medical Isotopes to be Produced in Wisconsin

Nukewatch Quarterly Spring 2016

The Nuclear Regulatory Commission on February 25 granted a construction permit to SHINE Medical Technologies to build a $100 million factory in Janesville, Wisconsin where it will produce Molybdenum-99, or Mo-99, and other radioisotopes. Mo-99 decays to technicium-99m which is used in medical scans for cancer, heart function screening, and other procedures. Based in Monona, Wisconsin and established in 2010, SHINE expects to open the factory in three years and produce over one quarter of the global demand for Mo-99.

SHINE says it uses a “patented, proprietary manufacturing process” for producing the isotopes that does not require a nuclear reactor or highly enriched uranium. SHINE’s website says its process “uses less electricity, generates less waste” than conventional production methods practiced inside CANDU reactors in Canada—the current source of most medical isotopes used in the US.

Technitium-99m is used as a radioactive “tracer” isotope in up to 40 million medical imaging procedures in the US each year. According to SHINE, tc-99m “is administered to some 55,000 Americans every day for the purpose of diagnosing and staging a multitude of diseases, including cancer and heart disease.” It is an imaging agent in bone scans to identify the stage of a cancer, and in stress tests to diagnose heart disease. Other radioisotopes produced by SHINE include iodine-131, iodine-125, and xenon-133 gas.

—Minneapolis StarTribune, Feb. 26, 2016; & <http://shinemed.com/news/shine-medical-receives-regulatory-approval-nuclear-regulatory-commission-to-issue-construction-permit>

Filed Under: Newsletter Archives, Quarterly Newsletter, Uncategorized

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Connected

  • Facebook
  • Twitter

Subscribe

Donate

Facebook

Categories

  • B61 Bombs in Europe
  • Chernobyl
  • Counterfeit Reactor Parts
  • Depleted Uranium
  • Direct Action
  • Environment
  • Environmental Justice
  • Fukushima
  • Lake Superior Barrels
  • Military Spending
  • Newsletter Archives
  • North Korea
  • Nuclear Power
  • Nuclear Weapons
  • Office News
  • On The Bright Side
  • Photo Gallery
  • Quarterly Newsletter
  • Radiation Exposure
  • Radioactive Waste
  • Renewable Energy
  • Sulfide Mining
  • Through the Prism of Nonviolence
  • Uncategorized
  • Uranium Mining
  • US Bombs Out of Germany
  • War
  • Weekly Column

Contact Us

(715) 472-4185
nukewatch1@lakeland.ws

Address:
740A Round Lake Road
Luck, Wisconsin 54853
USA

Donate To Nukewatch

News & Information on Nuclear Weapons,
Power, Waste & Nonviolent Resistance

Stay Connected

  • Facebook
  • Twitter

© 2023 · Nukewatch